Technvision Ventures [TECHNVISN] vs Nucleus Software [NUCLEUS] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Technvision Ventures wins in 4 metrics, Nucleus Software wins in 15 metrics, with 0 ties. Nucleus Software appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricTechnvision VenturesNucleus SoftwareBetter
P/E Ratio (TTM)10,361.1115.72Nucleus Software
Price-to-Book Ratio420.743.23Nucleus Software
Debt-to-Equity Ratio25.930.25Nucleus Software
PEG Ratio-105.140.85Technvision Ventures
EV/EBITDA878.8713.42Nucleus Software
Profit Margin (TTM)-0.86%19.66%Nucleus Software
Operating Margin (TTM)1.80%14.05%Nucleus Software
EBITDA Margin (TTM)1.80%14.05%Nucleus Software
Return on Equity0.70%20.02%Nucleus Software
Return on Assets (TTM)0.06%14.14%Nucleus Software
Free Cash Flow (TTM)$76.96M$1.36BNucleus Software
Dividend YieldN/A1.08%N/A
1-Year Return27.43%-20.51%Technvision Ventures
Price-to-Sales Ratio (TTM)13.973.09Nucleus Software
Enterprise Value$29.71B$22.85BTechnvision Ventures
EV/Revenue Ratio12.702.67Nucleus Software
Gross Profit Margin (TTM)23.81%33.15%Nucleus Software
Revenue per Share (TTM)$376$323Technvision Ventures
Earnings per Share (Diluted)$-3.12$63.52Nucleus Software
Beta (Stock Volatility)0.43-0.33Nucleus Software
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Technvision Ventures vs Nucleus Software Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Technvision Ventures0.19%2.11%-19.85%36.25%-20.56%52.94%
Nucleus Software-0.50%-5.24%-2.63%-15.73%23.83%-3.80%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Technvision Ventures27.43%2,134.06%2,474.99%2,474.99%2,474.99%2,474.99%
Nucleus Software-20.51%151.96%48.17%328.96%623.48%609.85%

News Based Sentiment: Technvision Ventures vs Nucleus Software

Technvision Ventures

News based Sentiment: NEGATIVE

September brought a concerning mix of negative developments for Technvision Ventures, including a significant profit decline, stock price drops, and increased selling pressure. While long-term performance remains strong, the short-term headwinds create uncertainty and warrant careful investor attention. The insider sale adds another layer of complexity to the investment story.

View Technvision Ventures News Sentiment Analysis

Nucleus Software

News based Sentiment: MIXED

September presented a mixed bag for Nucleus Software, with positive business developments like the Finnovex award and Saarathi Finance partnership being significantly offset by the SEBI penalty for insider trading. While long-term performance remains strong, the governance concerns create uncertainty and require close monitoring, making this a month of both opportunity and risk.

View Nucleus Software News Sentiment Analysis

Performance & Financial Health Analysis: Technvision Ventures vs Nucleus Software

MetricTECHNVISNNUCLEUS
Market Information
Market Cap i₹33.55B₹26.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i23813,612
90 Day Avg. Volume i62713,347
Last Close₹5,205.35₹998.40
52 Week Range₹2,949.75 - ₹8,000.00₹725.00 - ₹1,378.00
% from 52W High-34.93%-27.55%
All-Time High₹8,000.00 (Mar 17, 2025)₹1,787.50 (Jan 22, 2024)
% from All-Time High-34.93%-44.15%
Growth Metrics
Quarterly Revenue Growth0.09%0.11%
Quarterly Earnings Growth-0.99%0.17%
Financial Health
Profit Margin (TTM) i-0.01%0.20%
Operating Margin (TTM) i0.02%0.14%
Return on Equity (TTM) i0.01%0.20%
Debt to Equity (MRQ) i25.930.25
Cash & Liquidity
Book Value per Share (MRQ)₹12.37₹309.29
Cash per Share (MRQ)₹87.80₹136.33
Operating Cash Flow (TTM) i₹27.25M₹2.28B
Levered Free Cash Flow (TTM) i₹1.14M₹1.63B
Dividends
Last 12-Month Dividend Yield iN/A1.08%
Last 12-Month Dividend iN/A₹12.50

Valuation & Enterprise Metrics Analysis: Technvision Ventures vs Nucleus Software

MetricTECHNVISNNUCLEUS
Price Ratios
P/E Ratio (TTM) i10,361.1115.72
Forward P/E iN/A35.47
PEG Ratio i-105.140.85
Price to Sales (TTM) i13.973.09
Price to Book (MRQ) i420.743.23
Market Capitalization
Market Capitalization i₹33.55B₹26.41B
Enterprise Value i₹29.71B₹22.85B
Enterprise Value Metrics
Enterprise to Revenue i12.702.67
Enterprise to EBITDA i878.8713.42
Risk & Other Metrics
Beta i0.43-0.33
Book Value per Share (MRQ) i₹12.37₹309.29

Financial Statements Comparison: Technvision Ventures vs Nucleus Software

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)TECHNVISNNUCLEUS
Revenue/Sales i₹566.16M₹2.18B
Cost of Goods Sold i₹431.36M₹1.46B
Gross Profit i₹134.79M₹721.70M
Research & Development iN/AN/A
Operating Income (EBIT) i₹5.11M₹305.80M
EBITDA i₹18.03M₹519.40M
Pre-Tax Income i₹5.23M₹483.00M
Income Tax i₹4.94M₹131.00M
Net Income (Profit) i₹289,000₹352.00M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)TECHNVISNNUCLEUS
Cash & Equivalents i₹5.35M₹501.60M
Total Current Assets i₹1.41B₹5.44B
Total Current Liabilities i₹1.35B₹2.83B
Long-Term Debt i₹102.25M₹8.80M
Total Shareholders Equity i₹163.07M₹8.14B
Retained Earnings i₹-3.40M₹7.67B
Property, Plant & Equipment i₹4.62M₹470.30M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)TECHNVISNNUCLEUS
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTECHNVISNNUCLEUS
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i23813,612
Average Daily Volume (90 Day) i62713,347
Shares Outstanding i6.28M26.33M
Float Shares i862,0876.61M
% Held by Insiders i0.93%0.76%
% Held by Institutions i0.00%0.03%

Dividend Analysis & Yield Comparison: Technvision Ventures vs Nucleus Software

MetricTECHNVISNNUCLEUS
Last 12-Month Dividend iN/A₹12.50
Last 12-Month Dividend Yield iN/A1.08%
3-Year Avg Annual Dividend iN/A₹11.67
3-Year Avg Dividend Yield iN/A0.93%
3-Year Total Dividends iN/A₹35.00
Ex-Dividend DateN/AJul 11, 2025